<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>46</volume><submitter>Moon J</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Stroke remains the second leading cause of death in Korea. This study was designed to estimate the crude, age-adjusted and age-specific incidence rates, as well as the case fatality rate of stroke, in Korea from 2011 to 2020.&lt;h4>Methods&lt;/h4>We utilized data from the National Health Insurance Services from January 1, 2002 to December 31, 2020, to calculate incidence rates and 30-day and 1-year case fatality rates of stroke. Additionally, we determined sex and age-specific incidence rates and computed age-standardized incidence rates by direct standardization to the 2005 population.&lt;h4>Results&lt;/h4>The crude incidence rate of stroke hovered around 200 (per 100,000 person-years) from 2011 to 2015, then surged to 218.4 in 2019, before marginally declining to 208.0 in 2020. Conversely, the age-standardized incidence rate consistently decreased by 25% between 2011 and 2020. When stratified by sex, the crude incidence rate increased between 2011 and 2019 for both sexes, followed by a decrease in 2020. Age-standardized incidence rates displayed a downward trend throughout the study period for both sexes. Across all age groups, the 30-day and 1-year case fatality rates of stroke consistently decreased from 2011 to 2019, only to increase in 2020.&lt;h4>Conclusions&lt;/h4>Despite a decrease in the age-standardized incidence rate, the total number of stroke events in Korea continues to rise due to the rapidly aging population. Moreover, 2020 witnessed a decrease in incidence but an increase in case fatality rates.</pubmed_abstract><journal>Epidemiology and health</journal><pagination>e2024003</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10928468</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence and case fatality of stroke in Korea, 2011-2020.</pubmed_title><pmcid>PMC10928468</pmcid><pubmed_authors>Shin S</pubmed_authors><pubmed_authors>Yum KS</pubmed_authors><pubmed_authors>Kim E</pubmed_authors><pubmed_authors>Seo Y</pubmed_authors><pubmed_authors>Baek JH</pubmed_authors><pubmed_authors>Lee HH</pubmed_authors><pubmed_authors>Kim YD</pubmed_authors><pubmed_authors>Kim HC</pubmed_authors><pubmed_authors>Lee H</pubmed_authors><pubmed_authors>Kaneko F</pubmed_authors><pubmed_authors>Moon J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence and case fatality of stroke in Korea, 2011-2020.</name><description>&lt;h4>Objectives&lt;/h4>Stroke remains the second leading cause of death in Korea. This study was designed to estimate the crude, age-adjusted and age-specific incidence rates, as well as the case fatality rate of stroke, in Korea from 2011 to 2020.&lt;h4>Methods&lt;/h4>We utilized data from the National Health Insurance Services from January 1, 2002 to December 31, 2020, to calculate incidence rates and 30-day and 1-year case fatality rates of stroke. Additionally, we determined sex and age-specific incidence rates and computed age-standardized incidence rates by direct standardization to the 2005 population.&lt;h4>Results&lt;/h4>The crude incidence rate of stroke hovered around 200 (per 100,000 person-years) from 2011 to 2015, then surged to 218.4 in 2019, before marginally declining to 208.0 in 2020. Conversely, the age-standardized incidence rate consistently decreased by 25% between 2011 and 2020. When stratified by sex, the crude incidence rate increased between 2011 and 2019 for both sexes, followed by a decrease in 2020. Age-standardized incidence rates displayed a downward trend throughout the study period for both sexes. Across all age groups, the 30-day and 1-year case fatality rates of stroke consistently decreased from 2011 to 2019, only to increase in 2020.&lt;h4>Conclusions&lt;/h4>Despite a decrease in the age-standardized incidence rate, the total number of stroke events in Korea continues to rise due to the rapidly aging population. Moreover, 2020 witnessed a decrease in incidence but an increase in case fatality rates.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-06-25T03:15:50.292Z</modification><creation>2025-04-04T21:30:38.085Z</creation></dates><accession>S-EPMC10928468</accession><cross_references><pubmed>38186243</pubmed><doi>10.4178/epih.e2024003</doi></cross_references></HashMap>